Investor profile
Kate Bingham
Private equity, Venture capital & Managing Partner at SV Health Investors' Dementia Discovery Fund (DDF)
Kate Bingham works as a Managing Partner at SV Health Investors' Dementia Discovery Fund (DDF). The firm's known portfolio counts 11 companies.
Is Kate Bingham a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechDementia therapeuticsDiagnosticsDrug DiscoveryHealthcare OperationsMedTechMedical DevicesPharma
Contacts
Affiliated funds' portfolios
Managing Partner at SV Health Investors' Dementia Discovery Fund (DDF), whose known portfolio counts 11 companies
- Artios Pharma
- TRex Bio
- Therini Bio
- Imbria Pharmaceuticals
- Mestag Therapeutics
- Enara Bio
- PayMedix
- Alchemab Therapeutics
- Draig Therapeutics
- Dualitas Therapeutics
- Adimab
Investor Profile
Kate Bingham is listed against sector Healthcare, and focus areas Biotech, Dementia therapeutics, Diagnostics and Drug Discovery in the database.
SV Health Investors' Dementia Discovery Fund (DDF) appears in Growth, Late-Stage and Seed rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Kate Bingham matches their raise.
Colleagues at SV Health Investors' Dementia Discovery Fund (DDF)
Dirk Landgraf
Principal
Boston, United States
Jamil M. Beg
Partner
Cambridge, United States
Brent Faduski
CFO and Partner
United States
A.J. Rossi
Investor
Boston, United States
Tom Flynn
Managing Partner
Boston, United States
Michael Balmuth
Managing Partner
Boston, United States
Paul LaViolette
Managing Partner & Chief Operating Officer
Boston, United States
Jonathan Behr
Partner
Cambridge, United States
Bruce Peacock
Vnture Partner
Berwyn, United States
Nikola Trbovic
Managing Partner
New York City, United States
James Costine
Director
London, United Kingdom
Charles Dunn
Principal
United Kingdom
James Garvey
Managing Partner
Boston, United States
Gregory Madden
Managing Partner
Boston, United States
Georgina Ewels
Investor
London, United Kingdom
Eugene Hill
Managing Partner
Boston, United States
Mike Ross
Senior Partner
San Mateo, United States
Frequently asked questions
Who is Kate Bingham?
Kate Bingham is a private equity investor and venture capital investor based in London, England, United Kingdom, listed as Managing Partner at SV Health Investors' Dementia Discovery Fund (DDF). The known portfolio of that firm counts 11 companies. That portfolio belongs to the firm, not to Kate Bingham personally.
What does Kate Bingham invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Dementia therapeutics, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Kate Bingham invest at?
SV Health Investors' Dementia Discovery Fund (DDF) appears in Growth, Late-Stage and Seed rounds across its known deals, and Kate Bingham is listed there as Managing Partner. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Kate Bingham listed at?
Kate Bingham is listed as Managing Partner at SV Health Investors' Dementia Discovery Fund (DDF). 17 other people in the database share a firm with Kate Bingham.
How do I contact Kate Bingham?
An email address, a phone number and a LinkedIn page are on file for Kate Bingham. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal